期刊文献+

磁珠法结合定量PCR检测肠道病毒71型灭活疫苗中宿主细胞DNA残留量的验证及应用 被引量:2

Validation and application for determination of residual host cell DNA in enterovirus 71 inactivated vaccine by magnetic bead based extraction combined with quantitative PCR
原文传递
导出
摘要 目的对磁珠法结合定量PCR(quantitative PCR,qPCR)检测肠道病毒71型灭活疫苗(Vero细胞)(EV71疫苗)中宿主DNA残留量进行适用性验证及应用。方法利用微磁珠与蛋白溶液中DNA的特异性结合,来提取样品中残留的宿主细胞DNA。将已知浓度的细胞DNA对照系列稀释后,作为标准品DNA与提取的DNA同时进行qPCR扩增。根据标准品DNA的循环阈值与浓度之间的线性关系,对未知样品中残留DNA进行定量分析。结果标准品检测范围在0.03~3000.00Pg/反应。该方法的标准曲线决定系数≥O.980,扩增效率为90.O%~110.00。质控样品回收率为50%~150%,相对标准偏差均小于30%。实验结果的各项参数均在要求范围内。结论磁珠法可解决残留DNA检测中样品前处理的技术难点,qPCR能够简便、快速、准确地对EVTl疫苗生产过程中的DNA残留量进行定量测定。该法适用于EV71疫苗中DNA残留量的检测及疫苗生产过程和其成品的质量控制,对其他采用同样细胞基质的病毒性疫苗质量控制具有借鉴意义。 Objective To verify the detection method for residual host cell DNA in enterovirus 71 inactivated vaccine (Veto cell) (EV7l vaccine) by magnetic bead based extraction combined with quantitative PCR (qPCR). Methods Residual host cell DNA in samples was extracted utilizing the specific binding of magnetic bead to DNA in protein solution, qPCR was performed on extracted DNA and serial diluted standards simultaneously. Residual DNA in samples was quantitatively analyzed according to the linear relationship between cycle threshold values and concentrations of standards. Results The standard detection range was 0. 03-3 000. 00 pg/reaction. The correlation coefficient of standard curve was :〉0. 980, with amplification efficiency at 90. 0%-110. 0%. The recovery rates of spiked samples were 50%-150%, and the relative standard deviation was 〈30%. All parameters of results were within the required range. Conclusions The magnetic bead based extraction method can solve technical difficulties in sample pretreatment for residual DNA assay, qPCR is a simple, rapid and accurate method for quantitation of residual DNA in EV7l vaccine. This method is suitable for quality control of EV7l vaccine in production,and may provide indication for quality control of other same cell based viral vaccines.
作者 张静静 宋路萍 安文琪 马小伟 梁雪爽 郭冰峰 荆新蕊 马超援 张少宁 毕利利 王斌 Zhang Jingjing;Song Luping;An Wenqi;Ma Xiaowei;Liang Xueshuang;Guo Bingfeng;Jing Xinrui;Ma Chaoyuan;Zhang Shaoning;Bi Lili;Wang Bin.(Research and Development Center, Hualan Biological Engineering Inc., Xinxiang 453000, Chin)
出处 《国际生物制品学杂志》 CAS 2018年第3期123-127,共5页 International Journal of Biologicals
关键词 定量聚合酶链反应 Veto细胞 DNA残留 磁珠法 宿主细胞 Quantitative polymerase chain reaction Vero ceils Residual DNA Magnetic beadbased extraction Host cell
  • 相关文献

参考文献3

二级参考文献60

  • 1饶春明,赵阳,李永红,王军志.应用荧光法测定重组细胞因子中残余DNA含量[J].药物分析杂志,2005,25(12):1417-1419. 被引量:22
  • 2EU. Position statement on the use of tumorigenic cells of human origin for the production of biological and bioteehnological medicinal products. The European Agency for the Evaluation of Medieinal Products : Evaluation of medicinal products for human use. CPMP/BWP/1143/ 00 2001.
  • 3FDA. Points to consider in the manufacture and testing of monoclonal antibody products for human use. US Department of Health and Human Services,Food and Drug Administration, Center for Biologics Evaluation and Research 1997.
  • 4WANG Jun-zhi(王军志).Research & Development and Quality Control of Biotechnical Drugs(2nd Ed)(生物技术药物研究开发和质量控制)(第二版).Beijing(北京):Science Press(科学出版社),2007.98.
  • 5Singer VL, Jones LJ, Yue ST, et al. Characterization of PicoGreen reagent and development of a fluorescence - based solution assay for double - stranded DNA quantitation. Anal Biochem, 1997,249 ( 2 ) : 228.
  • 6苗玉发,王欣,沈连忠,李波.治疗性HIV腺病毒载体疫苗的生物分布[J].毒理学杂志,2007,21(4):313-314. 被引量:3
  • 7中国药典[S].三部,2010:附录48-49.
  • 8WHO Expert Committee on Biological Standardization. Forty-seventh Report. Requirements for the use of animal ceils as in vitro substrates for the production of biologicals [ R ]. Geneva: World Health Organization, 1998 (WHO Technical Report Series, No. 878, annex 1).
  • 9WHO Study Group. Acceptability of cell substrates for production of biologicals [ R ]. 1987 ( W HO Technical Report Series, No 747 ).
  • 10WHO Expert Committee on Biological Standardization. Thirtysixth Report. Requirements for continuous cell lines used for biological production [ R ]. Geneva: World Health Organization, 1987, Annex 3 ( WHO Technical Report Series, No. 745 ).

共引文献60

同被引文献7

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部